Glycomimetic selectin inhibitors: (α-D-mannopyranosyloxy)methylbiphenyls

Bioorganic and Medicinal Chemistry Letters

Volumn 6, Issue 5, 1996, Pages 569-572

  Dupré, Brian ^a   Bui, Huong ^a   Scott, Ian L ^a   Market, Robert V ^a   Keller, Karin M ^a   Beck, Pamela J ^a   Kogan, Timothy P ^a  

^a TEXAS BIOTECHNOLOGY CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIPHENYL DERIVATIVE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; PADGEM PROTEIN; TBC 265; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ADHESION; CELL STRAIN HL 60; CONTROLLED STUDY; DRUG DESIGN; DRUG SYNTHESIS; HUMAN; HUMAN CELL; STRUCTURE ACTIVITY RELATION;

EID: 0029988149     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-894X(96)00071-6     Document Type: Article

References (22)

1. Springer, T. A. Nature 1990, 346, 425.
2. Walz, G.; Aruffo, A.; Kolanus, W.; Bevilacqua, M.; Seed, B. Science 1990, 250, 1132.
3. (a) Sharon, N.; Lis, H. Science 1989, 246, 227.
4. (b) Phillips, M. L.; Nudelman, E.; Gaeta, F. C. A.; Perez, M.; Singhal, A. K.; Hakomori, S.-I.; Paulson, J. C. Science 1990, 250, 1130.
5. (c) Weis, W. I. Current Biology 1994, 2, 147.
6. (d) Erbe, D. V.; Wolitzky, B. A.; Presta, L. G.; Norton, C. R.; Ramos, R. J.; Burns, D. K.; Rumberger, J. M.; Narasinga Rao, B. N.; Foxall, C.; Brandley, B. K.; Lasky, L. A. J. Cell Biology 1992, 119, 215.
7. (a) Bevilacqua, M. P.; Nelson, R. M. J. Clin. Invest. 1993, 91, 379.
8. (b) Lee, M. Med. Sci. Res. 1992, 20, 539.
9. (c) Erbe, D. V.; Watson, S. R.; Presta, L. G.; Wolitzky, B. A.; Foxall, C.; Brandley, B. K.; Lasky, L. A. J. Cell Biology 1993, 120, 1227.
10. (d) Paulson, J. C. in Adhesion: its role in inflammatory disease; Harlan, J.; Liu, D., eds.; H. W. Freeman; New York, 1992; Chapt. 2, p 19.
11. (e) Erbe, D. V.; Wolitsky, B. A.; Presta, L. G.; Norton, C. R.; Ramos, R. J.; Burns, D. K.; Rumberger, J. M.; Rao, B. N. N.; Foxall, C.; Brandley, B. K.; Lasky, L. A. J. Cell Biol. 1992, 119, 215.
12. Kogan, T. P.; Dupré, B.; Beck, P. J.; Keller, K. M.; Scott, I. L.; Bui, H.; Market, R. V.; Voytus, J. A.; Revelle, B. M.; Scott, D. J. Med. Chem. 1995, 38, 4976.
13. (a) Allanson, N. M.; Davidson, A. H.; Floyd, C. D.; Martin, F. M. Tetrahedron: Asymmetry, 1994, 5, 2061.
14. (b) Uchiyama, T.; Vassilev, V.; Kajimoto, T.; Wong, W.; Huang, H.; Lin, C.-C.; Wong, C.-H. J. Am. Chem. Soc. 1995, 117, 5395.
15. (c) Kaila, N.; Yu, H.-A.; Xiang, Y. Tetrahedron Lett. 1995, 36, 5503.
16. (d) Prodger, J. C.; Bamford, M. J.; Gore, P. M.; Holmes, D. S.; Saez, V.; Ward, P. Tetrahedron Lett., 1995, 36, 2339.
17. (a) Miyaura, N.; Yanagi, T.; Suzuki, A. Synth, Commun. 1981, 11, 513.
18. For other recent examples of palladium-mediated couplings of aryl halides with aryl boronic acids see: (b) Rocca, P.; Marsais, F.; Godard, A.; Quéguiner, G. Tetrahedron Lett. 1994, 35, 2003.
19. (c) Alo, B. I.; Kandil, A.; Patil, P. A.; Sharp, M. J.; Siddiqui, M. A.; Snieckus, V.; Josephy, P. D. J. Org. Chem. 1991, 56, 3763.
20. 9· 0.25 TFA: requires C, 57.5; H, 5.4 %.
21. See also Kogan, T. P.; Dupré, B.; Scott, I. L.; Keller, K. M.; Dao, H.; Beck, P. J.; US patent 5,444,050, August 22, 1995.
22. Details of the assay have been reported previously: Kogan, T. P.; Revelle, B. M.; Tapp, S.; Scott, D.; Beck, P. J. J. Biol. Chem. 1995, 270, 14047, and reference 5.